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Median survival (month) p
p53 positive 5,03 0,2 
p53 negative 8,2
Ki67 positive 5,3 0,5
Ki67 negative 8,4
EGFR positive 5,3 0,5
EGFR negative 8,2
 Median survival (months) p
PS = 0 11,8 10-6 
PS =1 4,1
PS = 2 1,6
Age less 59 years 5,4 0,9
Age > 59 years 8,2
Female 7,5 0,5
Male 5
N0 9,7 0,008
N1 1,3
N2 8,3
N3 5,2
Conclusions: At this time of the study, there was no relation between 
expression of p53, EGFR, cell proliferation deﬁned by ki67 and surviv-
al. Correlation between PS, nodes extension and survival is conﬁrmed. 
Larger and longer follow-up studies may be needed to determine the 
prognostic role of expression of those new factors in NSCLC.
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Background: Postoperative radiotherapy (PORT) in completely 
resected NSCLC with mediastinal N2 metastases reduces the incidence 
of loco-regional recurrences. The LungART study is an international 
prospective trial to be activated in 2007, randomizing between PORT 
(54Gy) and observation. Although recent reports suggest that PORT 
could improve survival, a previous meta-analysis had suggested 
increased treatment-related mortality, underscoring the need to limit 
doses to the heart and lung using modern treatment techniques. IMRT 
is currently not permitted in the LungART trial due to concerns about 
radiation toxicity arising from an increase in lung volumes exposed to 
low doses. We performed a planning study to determine if dose-con-
straints for critical organs could be achieved in PORT after pneumonec-
tomy.
Methods: Conventional 3D (Eclipse TPS, Varian Medical Systems) 
and IMRT (Helios, VMS) planning techniques were compared in ﬁve 
post-pneumonectomy patients (3 right-sided and 2 left-sided). Both 
limited and extended target volumes were designed according to the 
LungART protocol. The limited target volume consists of the bron-
chial stump, ipsilateral hilus, nodal stations 4 and 7, and in the case of 
left sided tumors also stations 5-6. Extended volumes are used when 
stations 8-9 contain metastasis, and consist of the above, plus the para-
esophageal and pulmonary ligament nodes (stations 8 and 9). All target 
volumes were derived from 4-dimensional (4D) CT scans, incorporat-
ing movement. A 3D margin of 5 mm was added to derive planning 
target volumes (PTV). The planned dose was 54 Gy (1.8 Gy/ fraction), 
using the following constraints: maximum spinal cord dose 45 Gy; 
maximum dose of 35 Gy to ≤30% of the cardiac volume; maximum 
dose of 20 Gy to ≤15% of the lung volume. 
Results: For the limited PTVs, critical organ constraints were met in 
all cases for both conventional radiotherapy and IMRT. For extended 
PTVs, critical organ constraints could only be met using IMRT (Figure 
1). This could be achieved without increasing low dose lung volumes 
(V5). Using conventional techniques for the extended target volumes, 
cardiac doses signiﬁcantly exceeded the speciﬁed constraints.
Conclusions: The use of IMRT appears essential to reduce cardiac 
doses in patients whose PORT volumes include nodal stations 8 and 
9. The decision to exclude IMRT in the forthcoming LungART trial 
should be revised. Planning data on the beneﬁts of respiration-gated 
IMRT delivery for these patients will be available at the time of the 
meeting.
Figure 1: Dose levels (mean percentage in 5 patients) using either convention-
al radiotherapy or IMRT, in limited and extended target volumes. The maximal 
spinal dose was below 45Gy. Error bars represent minimum and maximum 
values.
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Occurrence of brain metastases in locally advanced NSCLC 
treated with radical radiotherapy (RT)
Hansen, Olfred; Hansen, Karin H.; Stolberg-Rohr, Anthi 
Odense University Hospital, Odense, Denmark
Occurrence of brain metastases (BM) is a major problem in NSCLC. 
To evaluate the inﬂuence on survival in locally advanced NSCLC 
treated with radical RT, a retrospective analysis was performed of the 
patients treated at our institution. 
Methods: From June 1995 to Feb. 2005 207 patients with non-resect-
able NSCLC stage IIB-IIIAB received radical 3-D conformal RT with 
a planned dose ≥60Gy/30 F. Data on BM were retrospectively obtained 
from the patient ﬁles. End points were occurrence of BM and survival. 
Min. follow-up was 24 months. 
